A Novel Polymorphism of the CYP4A11 Gene is Associated With Coronary Artery Disease

作者：Fu, Zhenyan; Ma, Yitong^*; Xie, Xiang; Huang, Ding; Yang, Hong; Nakayama, Tomohiro; Sato, Naoyuki

来源：Clinical and Applied Thrombosis/Hemostasis, 2013, 19(1): 60-65.

DOI：10.1177/1076029611436197

• CYP4A11
• single-nucleotide polymorphism
• case-control study

Background: CYP4A11 (cytochrome P450, family 4, subfamily A, polypeptide 11) converts arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which plays a crucial role in the modulation of cardiovascular homeostasis. The aim of the present study was to assess the association between the human CYP4A11 gene and coronary artery disease (CAD). Methods: A total of 361 patients with CAD and 315 controls were genotyped for 4 single-nucleotide polymorphisms (SNPs) of the human CYP4A11 gene (rs9332978, rs4660980, rs3890011, and rs1126742). The data were assessed for 3 groups: total participants, men, and women via case-control studies. Results: For total participants and men, the distribution of SNP3 (rs3890011) genotypes showed a significant difference between CAD and control participants (P = .030 and P = .013, respectively), the distribution of the recessive model of SNP3 (GG vs CC + GC) was significantly higher in CAD patients than in control participants (P = .011 and P = .014, respectively), the significant difference was retained after adjustment for covariates (for total participants, 95% confidence interval [CI]: 1.137-2.423, P = .009; and for males, 95% CI: 1.173-3.013, P = .009). Conclusions: rs3890011 maybe a novel polymorphism of the CYP4A11 gene associated with CAD in a Han Chinese population.

• 出版日期2013-2
• 单位新疆医科大学